Flecainide medication

Flecainide

Flecainide Acetate

Cardiovascular - Antiarrhythmic
Use of flecainide acetate tablets, USP for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospitalThe use of flecainide acetate tablets, USP are not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic
Dosage

50-150mg every 12 hours orally

Side Effects

DizzinessVisual disturbancesNauseaFatiguePalpitations

Share with friends

WhatsApp Telegram